Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diseases of the Thyroid

  Free Subscription


Articles published in Endocr J

Retrieve available abstracts of 69 articles:
HTML format
Text format



Single Articles


    June 2017
  1. SUGISAWA C, Higuchi S, Takagi M, Hasegawa Y, et al
    Homozygous DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother: Case report and review of the literature.
    Endocr J. 2017 Jun 16. doi: 10.1507/endocrj.EJ16-0564.
    PubMed     Text format     Abstract available


  2. TAKADA N, Hirokawa M, Suzuki A, Higuchi M, et al
    Reappraisal of "cyst fluid only" on thyroid fine-needle aspiration cytology.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ17-0082.
    PubMed     Text format     Abstract available


  3. XIN W, Yu Y, Ma Y, Gao Y, et al
    Thyroid-stimulating hormone stimulation downregulates autophagy and promotes apoptosis in chondrocytes.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ16-0534.
    PubMed     Text format     Abstract available


    May 2017
  4. INOUE N, Watanabe M, Nakaguchi A, Ueda D, et al
    Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.
    Endocr J. 2017 May 16. doi: 10.1507/endocrj.EJ16-0551.
    PubMed     Text format     Abstract available


    April 2017
  5. HIGUCHI S, Takagi M, Hasegawa Y
    Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
    Endocr J. 2017 Apr 18. doi: 10.1507/endocrj.EJ16-0559.
    PubMed     Text format     Abstract available


  6. KE W, Sun T, Zhang Y, He L, et al
    25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Endocr J. 2017 Apr 11. doi: 10.1507/endocrj.EJ16-0547.
    PubMed     Text format     Abstract available


    March 2017
  7. LI X, Zhen D, Zhao M, Liu L, et al
    Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study.
    Endocr J. 2017 Mar 7. doi: 10.1507/endocrj.EJ16-0549.
    PubMed     Text format     Abstract available


  8. YALCIN MM, Altinova AE, Cavnar B, Bolayir B, et al
    Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto's thyroiditis?
    Endocr J. 2017 Mar 4. doi: 10.1507/endocrj.EJ16-0418.
    PubMed     Text format     Abstract available


    February 2017
  9. TAKANO T
    Natural history of thyroid cancer [Review].
    Endocr J. 2017 Feb 2. doi: 10.1507/endocrj.EJ17-0026.
    PubMed     Text format     Abstract available


    December 2016
  10. KIM JW, Woo YJ, Yoon JS
    Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
    Endocr J. 2016;63:1133-1140.
    PubMed     Text format     Abstract available


  11. NOMURA R, Miyai K, Kuge R, Okura T, et al
    Free T3 to free T4 ratio less than 2.0 suggests low T3 syndrome rather than central hypothyroidism from the age of two to eighteen years.
    Endocr J. 2016 Dec 22. doi: 10.1507/endocrj.EJ16-0169.
    PubMed     Text format     Abstract available


    November 2016
  12. KOBAYASHI S, Yoshimura Noh J, Shimizu T, Sato T, et al
    A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  13. ITO Y, Hirokawa M, Miyauchi A, Kihara M, et al
    Diagnosis and surgical indications of oxyphilic follicular tumors in Japan: Surgical specimens and cytology.
    Endocr J. 2016;63:977-982.
    PubMed     Text format     Abstract available


  14. HE Y, Mu K, Liu R, Zhang J, et al
    Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  15. SATOH T, Isozaki O, Suzuki A, Wakino S, et al
    2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    September 2016
  16. ODA H, Miyauchi A, Ito Y, Sasai H, et al
    Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  17. YOSHIHARA A, Yoshimura Noh J, Mukasa K, Watanabe N, et al
    The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  18. AN JH, Kim SG
    L-carnitine supplementation in hypothyroidism [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  19. BENVENGA S, Sindoni A
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  20. SHINOHARA S, Kikuchi M, Harada H, Takebayashi S, et al
    The influence of American Society of Anesthesiologists Physical Status on patient morbidity and survival after total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  21. ITO Y, Hirokawa M, Miyauchi A, Masuoka H, et al
    Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  22. AN JH, Kim YJ, Kim KJ, Kim SH, et al
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  23. IDE A, Amino N, Nishihara E, Kudo T, et al
    Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  24. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  25. MATSUZAWA K, Izawa S, Okura T, Fujii S, et al
    Implications of FoxP3-positive and -negative CD4+ CD25+ T cells in Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  26. LESMANA R, Iwasaki T, Iizuka Y, Amano I, et al
    The change in thyroid hormone signaling by altered training intensity in male rat skeletal muscle.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  27. UEDA-SAKANE Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, et al
    Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  28. CAI TT, Zhang J, Wang X, Song RH, et al
    Gene-gene and gene-sex epistatic interactions of DNMT1, DNMT3A and DNMT3B in autoimmune thyroid disease.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  29. ITO Y, Suzuki S, Ito KI, Imai T, et al
    Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review].
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  30. KAGAWA T, Watanabe M, Inoue N, Otsu H, et al
    Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.
    Endocr J. 2016;63:375-80.
    PubMed     Text format     Abstract available


  31. KIHARA M, Miyauchi A, Kudo T, Hirokawa M, et al
    Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  32. ITO Y, Miyauchi A, Kihara M, Kudo T, et al
    Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  33. CHACHAMOVITZ DS, Vigario PD, Silva SO, Teixeira LB, et al
    Does low-normal serum TSH level adversely impact cognition in elderly adults and might methimazole therapy improve outcomes?
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  34. TRIMBOLI P, Centanni M, Virili C
    Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  35. LEE YS, Chang HS, Park CS
    Changing trends in the management of well-differentiated thyroid carcinoma in Korea.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  36. MUSSAZHANOVA Z, Akazawa Y, Matsuda K, Shichijo K, et al
    Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  37. SUZUKI S, Yamashita S, Fukushima T, Nakano K, et al
    The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  38. ONO Y, Fujita M, Ono S, Ogata S, et al
    A rabbit model of fatal hypothyroidism mimicking "myxedema coma" established by microscopic total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  39. KIM BY, Mok JO, Kang SK, Jang SY, et al
    The relationship between serum adipocytokines and Graves' ophthalmopathy: A hospital-based study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  40. CAI J, Fang Y, Jing D, Xu S, et al
    Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  41. HIROKAWA M, Sugitani I, Kakudo K, Sakamoto A, et al
    Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  42. TRIMBOLI P, Nigri G, Guidobaldi L, Romanelli F, et al
    Early diagnosis by FNA cytology should not influence the outcome of differentiated thyroid cancer.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  43. KIM GR, Shin JH, Hahn SY, Ko EY, et al
    Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  44. MORITANI S
    Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    December 2015
  45. TOMODA C, Ogimi Y, Saito F, Masaki C, et al
    Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  46. HASHIMOTO K, Tagami T, Yamakage H, Muranaka K, et al
    Serum free thyroxine levels is associated with the efficacy of weight reduction therapy in obese female patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  47. YOSHIOKA W, Miyauchi A, Ito M, Kudo T, et al
    Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  48. ITO Y, Oda H, Miyauchi A
    Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    November 2015
  49. UCHIDA T, Suzuki R, Kasai T, Onose H, et al
    Cutoff value of thyroid uptake of Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  50. MUKASA K, Yoshimura Noh J, Kouzaki A, Ohye H, et al
    TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  51. YOSHIE N, Watanabe M, Inoue N, Kawaguchi H, et al
    Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  52. KUNII Y, Uruno T, Mukasa K, Sekiya K, et al
    Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  53. OZKAN C, Akturk M, Altinova AE, Cerit ET, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  54. KAMMORI M, Fukumori T, Sugishita Y, Hoshi M, et al
    Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  55. HIRATSUKA I, Itoh M, Yamada H, Yamamoto K, et al
    Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  56. ISHIDO Y, Luo Y, Yoshihara A, Hayashi M, et al
    Follicular thyroglobulin enhances gene expression necessary for thyroid hormone secretion.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  57. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    July 2015
  58. GE JF, Xu YY, Li N, Zhang Y, et al
    Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  59. YI JW, Park JY, Sung JY, Kwak SH, et al
    Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  60. HANAOKA M, Arata N, Sago H
    Change of maternal thyroid function in twin-twin transfusion syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  61. TAMADA D, Kitamura T, Onodera T, Hamasaki T, et al
    Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  62. TAKESHIMA K, Inaba H, Ariyasu H, Furukawa Y, et al
    Clinicopathological features of Riedel's thyroiditis associated with IgG4-related disease in Japan.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    May 2015
  63. TAKESHIMA K, Ariyasu H, Inaba H, Inagaki Y, et al
    Distribution of serum immunoglobulin G4 levels in Hashimoto's thyroiditis and clinical features of Hashimoto's thyroiditis with elevated serum immunoglobulin G4 levels.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  64. KANG S, Amino N, Kudo T, Nishihara E, et al
    Occurrence of thyroxine tablet (Thyradin S) - induced liver dysfunction in a patient with subclinical hypothyroidism.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  65. WU H, Zhang B
    Ultrasonographic appearance of focal Hashimoto's thyroiditis: A single institution experience.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    January 2015
  66. FUKUHARA N, Horiguchi K, Nishioka H, Suzuki H, et al
    Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Endocr J. 2015;62:21-7.
    PubMed     Text format     Abstract available


  67. UEDA Y, Tagami T, Tamanaha T, Kakita M, et al
    A family of RTHbeta with p.R316C mutation presenting occasional syndrome of inappropriate secretion of TSH.
    Endocr J. 2015;62:251-60.
    PubMed     Text format     Abstract available


  68. NARUMI S, Hasegawa T
    TSH resistance revisited.
    Endocr J. 2015;62:393-8.
    PubMed     Text format     Abstract available


  69. SHIRAISHI M, Yamamoto Y, Hirooka N, Obuchi Y, et al
    A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells.
    Endocr J. 2015;62:431-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: